In addition, we also observed that high expression of MMP9 indicated higher levels of immune inhibitors (immune checkpoints), better response to immunotherapies, and poor survival in partial HCC patients, which was in line with our above analysis that some HCC patients with high CD8+ T cell infiltration but with dysfunction were immunosuppressed. This evidence concerns the gene MMP9 and hepatocellular carcinoma.